Chicago Barn to Wire BRIS
Home | News | Bloggers | Forums | Resources | Links | Marketplace | Gallery | Contact Us | Search


October 02, 2014, 01:31:43 AM *
Welcome, Guest. Please login or register.

Login with username, password and session length
News: If you don't remember your password, email me.

New  registration procedures -- Some ISPs have been bouncing the verification emails.  Please email me to be activated or if you have any problems.  Click Contact Us above.
 
   Home   Help Search Login Register  
Pages: [1]   Go Down
  Print  
Author Topic: Langley Appoints Medication Advisory Committee  (Read 449 times)
jrstark
Administrator
Hero Member
*****
Posts: 6146



« on: November 07, 2013, 12:07:43 PM »

In order to develop comprehensive proposals on the use of therapeutic medications and recommended penalties for violations in harness racing, President Phil Langley has appointed a diverse panel of experts to a new United States Trotting Association (USTA) medication advisory committee.
 
“Recognizing that some of the fault was that the USTA lacked sufficient scientific representation on the Racing Medication and Testing Consortium (RMTC),” said USTA President Phil Langley, “I have appointed a widely representative advisory committee to guide us in future medication proposals.”
 
The members of the USTA medication advisory committee are: eminent researchers Dr. George Maylin and Dr. Thomas Tobin; practicing veterinarians Dr. Jay Baldwin, Dr. Janet Durso and Dr. William Moffett; trainers Mark Ford, Sam Beegle, Ray Schnittker and David McCaffrey;  racing commissioners Bob Schmitz and Alan Leavitt;  attorneys Joe Faraldo and Chris Wittstruck;  racing investigator Brice Cote;  Hambletonian Society President and CEO Tom Charters; and Phil Langley, Mike Tanner, and T.C. Lane from the USTA.
 
As has been widely reported during the past few weeks, the USTA has struggled with acceptance of some of the RMTC and Association of Racing Commissoners International (RCI) proposed uniform medication rules – especially those regarding clenbuterol and corticosteroids.
 
“Under these proposed rules, both medications would become virtually useless in harness racing,” said USTA President Phil Langley.  “We are hopeful that after much discussion with RMTC and with testimony before racing commissions, some adjustments will be forthcoming.”
 
The USTA has already been working with the Pennsylvania horsemen groups to commission Dr. Larry Soma and Dr. Mary Robinson to conduct research on items like EPO, extracorporeal shock wave therapy and some of the unknown drugs that most threaten the integrity of harness racing.  Their research also is pursuing alternatives to clenbuterol and the adjustment of threshold levels that can be utilized with Standardbreds.
 
 
Dan Leary
Director of Marketing and Communications
USTA
Report to moderator   Logged
Pages: [1]   Go Up
  Print  
 
Jump to:  

Powered by MySQL Powered by PHP Powered by SMF 1.1.19 | SMF © 2013, Simple Machines Valid XHTML 1.0! Valid CSS!
Page created in 0.168 seconds with 17 queries.

Home
Upcoming events
Arlington Million
Horse slaughter in IL
Racing TV schedule
News Updates
Legislation

Galloping Out

Previous stories

Arlington
Balmoral
Hawthorne
Maywood
Chicago Sun-Times
Chicago Tribune
Blood-Horse
Daily Racing Form
Thoroughbred Times
Harness Link
Illinois Racing Board

 

2014

Arlington Million
Triple Crown
Illinois Derby

2013

Breeders' Cup
Hawthorne Gold Cup
Arlington Million
Triple Crown
Illinois Derby

2012

Breeders' Cup
Hawthorne Gold Cup
Arlington Million
Triple Crown
Illinois Derby

More ebay items

 

Home | News Updates | Bloggers | Forums | Search
Resources | Links | Marketplace | Gallery | Advertising | Contact Us

Copyright © 2000-2014 Chicago Barn to Wire. All rights reserved.
Privacy policy